We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AGN market cap is 54.86M. The company's latest EPS is AUD -0.0483 and P/E is -11.39.
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 0 | 0 | 296k | 259k | 1.75M |
Operating Income | -383k | 0 | -614k | -4.09M | -4.88M |
Net Income | -383k | 0 | -1.03M | -4.09M | -4.82M |
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 378k | 7.52M | 7.27M | 9.04M | 9.54M |
Total Liabilities | 359k | 58k | 426k | 736k | 1.88M |
Total Equity | 19k | 7.46M | 6.85M | 8.31M | 7.67M |
Year End 30 June 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -59k | N/A | -1.05M | -3.36M | -3.3M |
Investing | N/A | N/A | N/A | N/A | -50k |
Financing | 401k | N/A | 7.85M | 5.13M | 3.73M |
Market Cap | 54.86M |
Price to Earnings Ratio | -11.39 |
Price to Sales Ratio | 31.43 |
Price to Cash Ratio | 5.91 |
Price to Book Ratio | 7.16 |
Dividend Yield | - |
Shares Outstanding | 99.74M |
Average Volume (1 week) | 262.08k |
Average Volume (1 Month) | 244.67k |
52 Week Change | 25.00% |
52 Week High | 0.75 |
52 Week Low | 0.295 |
Spread (Intraday) | 0.02 (3.51%) |
Company Name | Argenica Therapeutics Limited |
Address |
unit 4 nedlands, western australia 6009 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions